Obesity Treatment Today: Patient-Centered Approaches to Improving Health Outcomes

More than one-third of adults in the United States are obese. It should come as no surprise that these individuals are at increased risk for cardiovascular disease, diabetes, certain cancers, and other significant comorbidities. If current trends continue, nearly 60% of US adults will be overweight or obese by 2030. New guidelines and pharmacotherapy are available to assist the medical community in its efforts to manage this disease. Experts in obesity share their insights on the latest approaches and treatment options for overweight and obese patients.

Collaborative Obesity Management in Practice CME
This case-based activity highlights counseling techniques effective for motivating management of weight in patients who are obese.

December 21, 2015
Diagnosing and Treating Patients Who Are Obese CME
Explore recently approved therapies to treat patients who are overweight and obese.

November 17, 2015
Obesity Management: Improving Outcomes by Engaging Patients CME/CE
Join our panel of experts in a discussion on partnering and engaging with patients in weight loss management plans

October 29, 2015
Successful Obesity Management and Counseling: A 360-Degree Perspective CME/CE
Join our experts in this discussion on effective obesity management and treatment

September 25, 2015
Obesity Treatment Today CME/CE
Challenge yourself with this self-assessment on managing patients who are overweight and obese and see how you compare with your peers.

September 25, 2015
Individualizing Obesity Management in the Modern Era CME/CE
Challenge your knowledge and skills in managing and treating obesity.

June 25, 2015
Team-Based Perspectives on Successful Approaches in Treating Obesity CME/CE
A multidisciplinary team of experts discuss strategies for successful obesity management.

May 18, 2015
The Truth About Modern Obesity Agents: Are They Really Safe and Effective? CME/CE
Join our multidisciplinary panel as they discuss the past and present of weight loss pharmacotherapy.

March 26, 2015

Steering Committee Chair

Ken Fujioka, MD
Director, Nutrition and Metabolic Research Center, Scripps Clinic, La Jolla, California

Steering Committee Members

Timothy Church, MD, MPH, PhD
Professor, Pennington Biomedical Research Center, Baton Rouge, Louisiana
Timothy Garvey, MD
Butterworth Professor and Chair, Department of Nutrition Sciences, University of Alabama at Birmingham; Director, UAB Diabetes Research Center; Investigator and Staff Physician, Geriatric Research, Education, and Clinical Center (GRECC), Birmingham VA Medical Center, Birmingham, Alabama
Patrick O'Neil, PhD
Director, Weight Management Center; Professor, Department of Psychiatry and Behavioral Sciences; Professor, Department of Surgery, Medical University of South Carolina, Charleston, South Carolina

Donna Ryan, MD
Professor Emeritus, Pennington Biomedical Research Center, Baton Rouge, Louisiana
Scott Kahan, MD, MPH
Faculty, Johns Hopkins University; Baltimore, Maryland; Director, National Center for Weight and Wellness, Washington, DC

This activity is supported by an
educational grant from

Takeda Pharmaceuticals U.S.A., Inc.

Downloadable Slide Kit

Managing Obesity in Your Clinical Practice
These slides provide an overview on addressing and appropriately managing obesity.

Clinical Articles

Steering Committee

Ken Fujioka, MD

Ken Fujioka, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Eisai Co., Ltd; Enteromedics, Inc.; Gelesis; Nazura; Novo Nordisk; Zafgen; Takeda Pharmaceuticals North America, Inc.
Served as a speaker or a member of a speakers bureau for: Abbott Laboratories; Eisai Co., Ltd; Novo Nordisk; Shire; Takeda Pharmaceuticals North America, Inc.
Received grants for clinical research from: Eisai Co., Ltd; Enteromedics, Inc.; Orexigen Therapeutics, Inc.; Novo Nordisk; Shire

Timothy Church, MD, MPH, PhD

Timothy Church, MD, MPH, PhD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: VIVUS Inc.
Received grants for clinical research from: VIVUS Inc.; Coca Cola; Orexigen Therapeutics, Inc.; Arena Pharmaceuticals, Inc.
Owns stocks, stocks options, or bonds from: Catapult Health; FIX: Fitness Interactive eXperience Employed by a commercial interest: ACAP Health

Timothy Garvey, MD

Timothy Garvey, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Daiichi Sankyo, Inc.; VIVUS Inc.; Eisai, Inc.; Takeda Pharmaceuticals North America, Inc.; Novo Nordisk; Janssen Pharmaceuticals, Inc.; LipoScience; Boehringer Ingelheim Pharmaceuticals, Inc.
Received grants for clinical research from: AstraZeneca Pharmaceuticals LP; Merck & Co., Inc.; Weight Watchers; Sanofi; Eisai, Inc.
Owns stocks, stocks options, or bonds from: Pfizer, Inc.; Lilly; Merck & Co., Inc.; Isis Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Novartis Pharmaceuticals Corporation

Patrick O'Neil, PhD

Patrick O'Neil, PhD, has disclosed the following relevant financial relationships:
Served as a speaker or a member of a speakers bureau for: Eisai Inc.; Novo Nordisk
Received grants for clinical research from: Orexigen Therapeutics, Inc.; Weight Watchers International; Novo Nordisk
Received reimbursement for travel expenses from: VIVUS, Inc.

Donna Ryan, MD

Donna Ryan, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Novo Nordisk; Eisai, Inc.; Takeda Pharmaceuticals North America, Inc.; VIVUS Inc.; Janssen Pharmaceuticals, Inc.
Served as a speaker or a member of a speakers bureau for: Takeda Pharmaceuticals North America, Inc.
Owns stocks, stocks options, or bonds from: Scientific Intake

Scott Kahan, MD, MPH

Participation by Dr Kahan as an advisor does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins Hospital and Health System.

Scott Kahan, MD, MPH, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Eisai Co., Ltd; Novo Nordisk; Takeda Pharmacueticals North America, Inc.; VIVUS Inc.
Received grants for clinical research from: Eisai Co., Ltd; Novo Nordisk; Takeda Pharmacueticals North America, Inc.; VIVUS Inc.
Book Royalties (Other): Johns Hopkins University Press; Lippincott Williams & Wilkins; Wolters-Kluwer

	Over the past year, how has your comfort level changed related to providing weight-loss options for your patients with overweight or obesity?
		Comfort level has increased
		Comfort level has decreased
		Has not changed -- always been comfortable
		Has not changed -- still not comfortable